Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315601 · ClinicalTrials.gov registry record · Phase 4
Intrapulmonary Pharmacokinetics of Antibiotics
A Phase 4 study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT00315601: Clinical Trial Phase 4 study, sponsored by University of Illinois at Chicago.
NCT00315601 is a Phase 4 study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 35 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315601, a Phase 4 study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The major objectives of this research are to see how much, and for how long, telithromycin and azithromycin get into the fluids and cells of the lung.
Interventions
- DRUG azithromycin
- DRUG Telithromycin
- PROCEDURE bronchoalveolar lavage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
Why NCT00315601 stopped before completion
NCT00315601 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which azithromycin is the first listed.
NCT00315601 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00315601 about?
NCT00315601 is a clinical study titled "Intrapulmonary Pharmacokinetics of Antibiotics". The major objectives of this research are to see how much, and for how long, telithromycin and azithromycin get into the fluids and cells of the lung.
What is the current status of trial NCT00315601?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2006-01. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00315601?
The interventions under investigation include: azithromycin (DRUG), Telithromycin (DRUG), bronchoalveolar lavage (PROCEDURE).
Who is sponsoring clinical trial NCT00315601?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00315601's enrollment target sits among peer trials
35 1506th of 2000 higher than 481 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia